Synthetic Biology-The New Engine for Corporate Profit Growth

In the pursuit of increasing corporate profitability, numerous raw material companies have turned their attention to synthetic biology, a hot track,

which is seen as a "universal key" to unlocking new profit spaces. In this field, companies such as Huaxi Bio,

Huahan Bio, and Jinbo Bio have gained a certain market influence and achieved product sales and commercialization through years of deep cultivation.

It is worth noting that despite less than ideal performance, Huaxi Bio continues to invest heavily in research and development.

In the first three quarters of this year, Huaxi Bio has continued to increase its investment in R&D,

with R&D expenses growing by 12.99% year-on-year to 313 million yuan, accounting for 8.08% of its revenue.

Huaxi Bio, which is in a critical transformation period, has regarded synthetic biology as an important direction for its transformation.

Although the transformation is full of challenges, it also harbors new opportunities.